Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of 4CMenB Vaccine Against Gonorrhea in MSM
NCT05766904Phase 3Active, not recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- May 2023
- Primary completion
- Sep 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal group B vaccine in gonorrhea, sponsored by The Chinese University of Hong Kong. Started May 2023; status: active, not recruiting.
02
Drugs
meningococcal group B vaccine
03
Conditions
gonorrhea
Beyond the preview
Go deeper on NCT05766904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05766904.